2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Tuesday, June 14, 2016

5:30pm-5:42pm: Predonation Prescription Narcotic Use: A Novel Risk Factor for Readmission After Living Donor Nephrectomy.

K. Lentine,^1,7 D. Segev,^2,1 D. Axelrod,³ N. Lam,⁴ A. Garg,⁵ G. Hess,⁶ B. Kasiske,¹ D. Brennan,⁸ H. Randall,⁷ M. Schnitzler.^7,1

Concurrent Session: Living Kidney Donor Evaluation • Ballroom B

5:30pm-5:42pm: Relative Distribution of Livers from HCV+ Donors in the U.S.

J. Salazar,¹ J. Roberts,¹ N. Mehta,¹ M. Volk,² J. Lai.¹

Concurrent Session: Liver: MELD, Allocation and Donor Issues (DCD/ECD) 2 • Room 304

5:30pm-5:42pm: Tailored Rabbit Anti-Thymocyte Globulin Induction (rATG) Dosing for Kidney Transplantation.

N. Singh,^1,2 A. Rossi,¹ M. Savic,¹ R. Rubocki,¹ M. Parker,¹ J. Vella.¹

Concurrent Session: Kidney: Induction Therapy 2 • Room 312

5:30pm-5:42pm: Type-I Interferon Induced Cross-Competition of IL-10 Signaling and Its Role in the Abrogation of Transplant Tolerance.

M. Iglesias, A. Arun, W. Lee, G. Brandacher, G. Raimondi.

Concurrent Session: Novel Approaches and Potential Targets for Promoting Tolerance: Animal Models • Room 310

5:30pm-5:42pm: Wait List Removals and Transplant Rates Are Significantly Associated with Transplant Center Performance Oversight.

J. Schold, L. Buccini, E. Poggio, S. Flechner, D. Goldfarb.

Concurrent Session: Kidney Waitlist Management and KAS Initial Results • Veterans Auditorium

5:42pm-5:54pm: Antithymocyte Globulin (ATG) versus Anti-interleukin-2 Receptor (Anti-IL-2R) as Induction Therapy for Kidney Transplantation After a Nonrenal Transplant.

H. Mai,¹ K. Trébern-Launay,¹ C. Legendre,² M. Kessler,³ L. Rostaing,⁴ V. Garrigue,⁵ E. Morelon,⁶ S. Brouard,¹ M. Giral,¹ J.-P. Soulillou.¹

Concurrent Session: Kidney: Induction Therapy 2 • Room 312

5:42pm-5:54pm: Better Never Than Late: Differences in Outcomes and Risk Factors for Early and Late Rejection After Kidney Transplantation.

A. Liu, N. Sarabu, A. Joshua.

Concurrent Session: Kidney Transplant Recipient: Long Term Outcomes Session 2 • Ballroom A

5:42pm-5:54pm: DNA Methylation Patterns and Association with Graft Injury Severity Post Liver Transplantation.

R. Gehrau, S. Bontha, V. Mas, D. Maluf.

Concurrent Session: Ischemia Reperfusion Injury: Clinical Innovation • Room 311

5:42pm-5:54pm: Early Post-Transplant Patient, Graft Survival and Rejection Rates Under KAS.

A. Kucheryavaya, D. Stewart, D. Klassen.

Concurrent Session: Diabetes and Obesity in Kidney Transplantation • Room 302

5:42pm-5:54pm: Effect of Adipose Tissue-Derived Mesenchymal Stem Cells in a Rat Model of Chronic Renal Allograft Rejection.

R. Pepineli, F. Silva, P. Gouveia, G. Tavora, S. Gomes, I. Noronha.

Concurrent Session: Bone Marrow Transplantation and Chimerism: Animal Models • Room 313